Literature DB >> 29242905

The Long Noncoding RNA Landscape of the Mouse Eye.

Weiwei Chen1,2, Shuai Yang1,2, Zhonglou Zhou1,2, Xiaoting Zhao1,2, Jiayun Zhong1,2, Peter S Reinach1,2, Dongsheng Yan1,2.   

Abstract

Purpose: Long noncoding RNAs (lncRNAs) are important regulators of diverse biological functions. However, an extensive in-depth analysis of their expression profile and function in mammalian eyes is still lacking. Here we describe comprehensive landscapes of stage-dependent and tissue-specific lncRNA expression in the mouse eye.
Methods: Affymetrix transcriptome array profiled lncRNA signatures from six different ocular tissue subsets (i.e., cornea, lens, retina, RPE, choroid, and sclera) in newborn and 8-week-old mice. Quantitative RT-PCR analysis validated array findings. Cis analyses and Gene Ontology (GO) annotation of protein-coding genes adjacent to signature lncRNA loci clarified potential lncRNA roles in maintaining tissue identity and regulating eye maturation during the aforementioned phase.
Results: In newborn and 8-week-old mice, we identified 47,332 protein-coding and noncoding gene transcripts. LncRNAs comprise 19,313 of these transcripts annotated in public data banks. During this maturation phase of these six different tissue subsets, more than 1000 lncRNAs expression levels underwent ≥2-fold changes. qRT-PCR analysis confirmed part of the gene microarray analysis results. K-means clustering identified 910 lncRNAs in the P0 groups and 686 lncRNAs in the postnatal 8-week-old groups, suggesting distinct tissue-specific lncRNA clusters. GO analysis of protein-coding genes proximal to lncRNA signatures resolved close correlations with their tissue-specific functional maturation between P0 and 8 weeks of age in the 6 tissue subsets. Conclusions: Characterizating maturational changes in lncRNA expression patterns as well as tissue-specific lncRNA signatures in six ocular tissues suggest important contributions made by lncRNA to the control of developmental processes in the mouse eye.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29242905     DOI: 10.1167/iovs.17-22178

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Delivery of Antisense Oligonucleotides to the Cornea.

Authors:  Viet Q Chau; Jiaxin Hu; Xin Gong; John D Hulleman; Rafael L Ufret-Vincenty; Frank Rigo; Thahza P Prakash; David R Corey; V Vinod Mootha
Journal:  Nucleic Acid Ther       Date:  2020-03-23       Impact factor: 5.486

2.  Non-coding RNAome of RPE cells under oxidative stress suggests unknown regulative aspects of Retinitis pigmentosa etiopathogenesis.

Authors:  Luigi Donato; Concetta Scimone; Carmela Rinaldi; Rosalia D'Angelo; Antonina Sidoti
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

3.  Volatile Evolution of Long Non-Coding RNA Repertoire in Retinal Pigment Epithelium: Insights from Comparison of Bovine and Human RNA Expression Profiles.

Authors:  Olga A Postnikova; Igor B Rogozin; William Samuel; German Nudelman; Vladimir N Babenko; Eugenia Poliakov; T Michael Redmond
Journal:  Genes (Basel)       Date:  2019-03-08       Impact factor: 4.096

4.  Systematic identification of intergenic long-noncoding RNAs in mouse retinas using full-length isoform sequencing.

Authors:  Ying Wan; Xiaoyang Liu; Dongwang Zheng; Yuying Wang; Huan Chen; Xiaofeng Zhao; Guoqing Liang; Dongliang Yu; Lin Gan
Journal:  BMC Genomics       Date:  2019-07-08       Impact factor: 4.547

5.  Effects of long non-coding RNA myocardial infarction-associated transcript on retinal neovascularization in a newborn mouse model of oxygen-induced retinopathy.

Authors:  Yu Di; Yue Wang; Xue Wang; Qing-Zhu Nie
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

Review 6.  Epigenetic regulation of retinal development.

Authors:  Reza Raeisossadati; Merari F R Ferrari; Alexandre Hiroaki Kihara; Issam AlDiri; Jeffrey M Gross
Journal:  Epigenetics Chromatin       Date:  2021-02-09       Impact factor: 4.954

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.